Helsinki - Delayed Quote EUR

BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

0.0666

-0.0006

(-0.89%)

At close: January 17 at 6:02:14 PM GMT+2

Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team

BBS-Bioactive Bone Substitutes Plc, Company announcement, 6 March 2024 at 11:15 a.m. Changes in the BBS-Bioactive Bone Substitutes Plc’s Management Team Oy Jamerco Ltd. has terminated its service contract with BBS-Bioactive Bone Substitutes Ltd (“BBS”). As a result, Jari Kortesluoma’s position as the CFO and member of the management team will end. Kortesluoma will fulfill the responsibilities of CFO throughout the two-month notice period. BBS is currently in the process of searching for a new in

GlobeNewswire 10 months ago

BONEH.HE
-0.89%
BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)

BBS-Bioactive Bone Substitutes Plc, Financial Statements Bulletin 2023, 26 February 2024 at 5.45 p.m. (EET) This is a summary of BBS-Bioactive Bone Substitutes Plc’s Financial Statements Bulletin for January–December 2023. The entire report is attached to this Company Announcement as a pdf file. The report is also available on BBS-Bioactive Bone Substitutes Plc’s website at https://www.bbs-artebone.fi/. Preparations for commercial phase initiated JULY-DECEMBER HIGHLIGHTS In the second half of 20

GlobeNewswire 10 months ago

BONEH.HE
-0.89%
Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position

BBS-Bioactive Bone Substitutes Plc, Company announcement, inside information, 21 February 2024 at 10:30 am EET Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position BBS-Bioactive Bone Substitutes Plc's (“BBS”, “the Company”) has signed the drawdown of the advance of EUR 500.000, pursuant to the terms and conditions of the Financing Agreement between BBS and RiverFort Global Opportunities Pcc Li

GlobeNewswire 10 months ago

BONEH.HE
-0.89%
BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself

BBS-Bioactive Bone Substitutes Plc, Company announcement, 31 January 2024 at 6.00 p.m. EET BBS-Bioactive Bone Substitutes has resolved on a share issue without consideration to the company itself BBS-Bioactive Bone Substitutes Plc's Board of Directors has decided on 31 January 2023 to issue 1,000,000 shares without consideration to the company itself, for potential loan conversions as well as for other possible purposes, in accordance with authorisation from the Extraordinary Shareholders' Meeti

GlobeNewswire 11 months ago

BONEH.HE
-0.89%

Performance Overview

Return	BONEH.HE	OMX Helsinki_PI
YTD	+25.66%	0.00%
1-Year	-86.15%	0.00%
3-Year	-96.50%	0.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

Changes in BBS-Bioactive Bone Substitutes Plc’s Management Team

BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)

Inside information - BBS-Bioactive Bone Substitutes Plc: Drawdown of an advance pursuant to financing arrangement between BBS-Bioactive Bone Substitutes Plc and RiverFort to strengthen the working capital position

BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself

Performance Overview